Ever Source Wealth Advisors, LLC Nuvalent, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 49 shares of NUVL stock, worth $3,826. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49
Previous 24
104.17%
Holding current value
$3,826
Previous $1,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NUVL
# of Institutions
216Shares Held
60.9MCall Options Held
319KPut Options Held
211K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.4 Billion32.3% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$411 Million19.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$347 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$236 Million0.01% of portfolio
-
Commodore Capital LP New York, NY1.86MShares$145 Million12.88% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.36B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...